Try our Advanced Search for more refined results

FDA Panel Backs Looser Limits On GSK's Avandia

By Jeff Overley (June 6, 2013, 5:30 PM EDT) -- A U.S. Food and Drug Administration panel on Thursday recommended dialing back restrictions on GlaxoSmithKline PLC's diabetes medicine Avandia after finding the risk of heart attacks had likely been overblown, but the move might be too late to restore the much-maligned drug's reputation....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections

Companies

Government Agencies

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!